SIA Biomedical Innovative Technologies EU

Key Facts

Enterprise Register · published 07/07/2022

Status
Legal form: Sabiedrība ar ierobežotu atbildību
Registration date: 19/08/2021
SEPA code: LV89ZZZ40203339482
Address: Ozolciema iela 12 k-2 – 88, Rīga, LV-1058
Region: 0
Equity capital: €2,800
NACE code: 46.1846.18 Activities of agents involved in the wholesale of other particular products
Industry sector: GG › 46 › 46.1 › 46.18
Historical names: 1

Status
Legal form: Sabiedrība ar ierobežotu atbildību
Registration date: 19/08/2021
SEPA code: LV89ZZZ40203339482
Address: Ozolciema iela 12 k-2 – 88, Rīga, LV-1058
Region: 0
Equity capital: €2,800
NACE code: 46.1846.18 Activities of agents involved in the wholesale of other particular products
Industry sector: GG › 46 › 46.1 › 46.18
Historical names: 1

Status

Enterprise Register · published 07/07/2022

No issues detected

Insolvency: None — Insolvency: None
Liquidation: None — Liquidation: None
VID suspensions: None — VID suspensions: None
Sanctions: None — Sanctions: None
Securing measures: None — Securing measures: None
Reorganization: None — Reorganization: None

Key Financials (2025)

data for 2025

Revenue

€0

Net income

-€44

Total assets

€2,800

Equity capital

€2,565

Employees

Profit margin

—

Current Ratio

11.91

ROA

-1.6%

Financial History

Insufficient data

Shareholders

Enterprise Register · published 07/07/2022

JUR.WR International AG

2,800

Beneficial Owners

Anatoly KhitrovRU

Officials

Executive Board

Šapošņikova Tatjana

Board Member

Power of Attorney

Enterprise Register · published 07/07/2022

No prokūra data

Timeline

07/07/2022

Appointed: Šapošņikova Tatjana — Board Member, Executive Board

08/02/2022

Beneficial owner declared: Anatoly Khitrov

27/01/2022

SIA shareholder: WR International AG (2800 shares)

20/12/2021

Name changed from SIA Morfix

24/08/2021

Capital: Apmaksātais pamatkapitāls 2800 EUR

19/08/2021

Company registered

19/08/2021

Founding registered

16/08/2021

Founding decision signed